CLEARFAST, INC. – Trademark Portfolio
Entity Type: 03
CLEARFAST, INC. holds 13 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 11 filings in this category. The portfolio also extends into Class 41 (Education & Entertainment) across 3 Nice Classification classes. Currently, 8 trademarks are registered. Notable registered marks include MENDWELL, CF(PREOP), CLEARFAST, CF(PROTEIN), and CF NUTRITION. The owner is based in CARDIFF, CA.
160 CHESTERFEILD DR. SUITE 101
CARDIFF, CA 92007
Showing of trademarks Trademarks
Trademark Classifications
CLEARFAST, INC.'s trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Education; providing of training; entertainment; sporting and cultural activities
Medical services; veterinary services; hygienic and beauty care for human beings or animals
Frequently Asked Questions
How many trademarks does CLEARFAST, INC. have?
CLEARFAST, INC. has 13 U.S. trademarks filed with the USPTO. Of these, 8 registered, 5 cancelled.
What trademark classes does CLEARFAST, INC. file in?
CLEARFAST, INC. files trademarks across 3 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 41 (Education & Entertainment), Class 44 (Medical Services). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.
What are CLEARFAST, INC.'s most well-known trademarks?
CLEARFAST, INC.'s registered trademark portfolio includes well-known marks such as MENDWELL, CF(PREOP), CLEARFAST, CF(PROTEIN), and CF NUTRITION. These are among 8 currently registered trademarks in the portfolio.
What is CLEARFAST, INC.'s trademark registration success rate?
CLEARFAST, INC. has a 62% trademark registration rate, with 8 out of 13 resolved applications resulting in successful registration. Currently, 0 applications are pending review.